
Exact Sciences Corporation
NASDAQ:EXAS
Overview | Financials
Company Name | Exact Sciences Corporation |
Symbol | EXAS |
Currency | USD |
Price | 46.35 |
Market Cap | 8,609,744,250 |
Dividend Yield | 0% |
52-week-range | 40.62 - 79.62 |
Industry | Diagnostics & Research |
Sector | Healthcare |
CEO | Mr. Kevin T. Conroy |
Website | https://www.exactsciences.com |
An error occurred while fetching data.
About Exact Sciences Corporation
Exact Sciences Corporation provides cancer screening and diagnostic test products in the United States and internationally. The company offers Cologuard, a non-invasive stool-based DNA screening test to detect DNA and hemoglobin biomarkers associated with colorectal cancer and pre-cancer. It also provides Oncotype DX, a gene expression tests for breast, prostate,
Related Stocks
Financials
Numbers are in millions USD
Numbers are in millions USD